News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Results>AKESO's Full-Yr Loss Expands to RMB1.113B
AKESO (09926.HK) has announced its 2025 annual results. Its revenue grew by 43.9% YoY to RMB3.056 billion, while gross profit rose by 31% to RMB2.404 billion.Because of an increase...
Reset
Send
The window will close in 5 seconds
<Results>AKESO's Full-Yr Loss Expands to RMB1.113B
Close
Recommend
3
Positive
4
Negative
9
 
 

AKESO (09926.HK)  -3.400 (-2.833%)    Short selling $132.92M; Ratio 22.332%   has announced its 2025 annual results. Its revenue grew by 43.9% YoY to RMB3.056 billion, while gross profit rose by 31% to RMB2.404 billion.

Dividend History
Announce DateEventParticular
2025/08/26InterimNo Dividend
2025/03/30FinalNo Dividend
2024/08/28InterimNo Dividend
2024/03/18FinalNo Dividend

Because of an increase of RMB256 million in impairment losses on equity investments in Summit Therapeutics and an increase of RMB387 million in R&D investment, AKESO's loss expanded from RMB515 million in the previous year to RMB1.113 billion, with loss per share at RMB1.23. No final dividend was declared.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)
Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.